Moderna wins FDA approval for Covid shot in at-risk kids; Makary, Prasad defend vaccine framework
The FDA on Thursday approved Moderna’s Covid-19 shot for kids six months through 11 years old who are at higher risk of severe disease, the …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
